Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock

Journal of Emergency Medicine

Volumn 44, Issue 2, 2013, Pages 434-439

  Hua, Feng ^a,b   Wang, Xiang ^b   Zhu, Lei ^a  

^a FUDAN UNIVERSITY   (China)

^b HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

acute respiratory distress syndrome; dopamine; oxygenation; terlipressin; vascular endothelial growth factor

Indexed keywords

DOPAMINE; TERLIPRESSIN; VASCULOTROPIN;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART HEMODYNAMICS; HUMAN; LUNG INJURY; MALE; MEAN ARTERIAL PRESSURE; OXYGENATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SHOCK;

BLOOD PRESSURE; DOPAMINE; DOPAMINE AGENTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LYPRESSIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTOR AGENTS;

EID: 84873197048     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2012.02.073     Document Type: Article

References (23)

1. D.R. Thickett, L. Armstrong, and A.B. Millar A role for vascular endothelial growth factor in acute and resolving lung injury Am J Respir Crit Care 166 2002 1332 1337
2. R.P. Dellinger, M.M. Levy, and J.M. Carlet Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock Intensive Care Med 2008 34 2008 17 60
3. D. De Backer, P. Biston, and J. Devriendt Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 2010 779 789
4. A. Delmas, M. Leone, S. Rousseau, J. Albanese, and C. Martin Clinical review: vasopressin and terlipressin in septic shock patients Crit Care 9 2005 212 222
5. A. Morelli, C. Ertmer, and S. Rehberg Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study Crit Care 13 2009 R130
6. G. Kalambokis, G. Baltayiannis, and S. Tsiouris Scintigraphic evaluation of intrapulmonary shunt in normoxemic cirrhotic patients and effects of terlipressin Hepatol Res 40 2010 1015 1021
7. P. Asfar, B. Hauser, and Z. Ivanyi Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism Crit Care Med 33 2005 373 380
8. G.R. Bernard, A. Artigas, and K.L. Brigham Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee J Crit Care 9 1994 72 81
9. G.D. Perkins, D.F. McAuley, D.R. Thickett, and F. Gao The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial Am J Respir Crit Care Med 173 2006 281 287
10. J.F. Murray, M.A. Matthay, J.M. Luce, and M.R. Flick An expanded definition of the adult respiratory distress syndrome Am Rev Respir Dis 138 1988 720 723
11. F. Ryckwaert, A. Virsolvy, and A. Fort Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance Crit Care Med 37 2009 876 881
12. A. Morelli, C. Ertmer, and M. Westphal "Terlipressin in the treatment of septic shock: the earlier the better"? Best Pract Res Clin Anaesthesiol 22 2008 317 321
13. S. Rehberg, C. Ertmer, and G. Kohler Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock Intensive Care Med 35 2009 1286 1296
14. A. Morelli, C. Ertmer, P. Pietropaoli, and M. Westphal Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock Expert Opin Pharmacother 10 2009 2569 2575
15. D.R. Thickett, L. Armstrong, S.J. Christie, and A.B. Millar Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome Am J Respir Crit Care Med 164 2001 1601 1605
16. J. Corne, G. Chupp, and C.G. Lee IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury J Clin Invest 106 2000 783 791
17. I. Kosmidou, D. Karmpaliotis, A.J. Kirtane, H.V. Barron, and C.M. Gibson Vascular endothelial growth factors in pulmonary edema: an update J Thromb Thrombolysis 25 2008 259 264
18. B. Maitre, S. Boussat, and D. Jean Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury Eur Respir J 18 2001 100 106
19. M. Westphal, H. Stubbe, and A.W. Sielenkamper Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport Intensive Care Med 29 2003 301 308
20. A. Morelli, C. Ertmer, and M. Lange Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study Br J Anaesth 100 2008 494 503
21. J. Albanese, M. Leone, A. Delmas, and C. Martin Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study Crit Care Med 33 2005 1897 1902
22. M. Lange, A. Morelli, and C. Ertmer Continuous versus bolus infusion of terlipressin in ovine endotoxemia Shock 28 2007 623 629
23. I. Matok, A. Vard, and O. Efrati Terlipressin as rescue therapy for intractable hypotension due to septic shock in children Shock 23 2005 305 310